Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Breakthrough Nears 50 Approvals: Process Improving, But “Gray Areas” Persist

May 09 2016

• By Kate Rawson

Related Content

FDA’s “Breakthrough” Exceeds Expectations; Will It Break The Bank?

Aug 09 2013

“Breakthrough Therapy”: New Pathway in FDASIA May Point The Way To Future Reforms

Aug 16 2012

FDA’s “Breakthrough” Evolves: What’s Next For The Popular Program?

Jul 29 2014

FDA Issues Wave Of "Breakthrough Therapy" Denials

Sep 17 2013

CDER Office of Pharmaceutical Quality Launches; Initial Impact On Manufacturers Is Minimal

Jan 15 2015

Breakthrough In Two Pages: FDA Offers Preliminary Advice

Mar 23 2016

Related Companies

Acadia Pharmaceuticals Inc.

Bristol Myers Squibb Company

AbbVie Inc.

Johnson & Johnson

Vertex Pharmaceuticals Incorporated

Additional Topics

United States Regulation BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window